Impact of immunopathology on the antituberculous activity of pyrazinamide.

Blanc L, Sarathy JP, Alvarez Cabrera N, O'Brien P, Dias-Freedman I, Mina M, Sacchettini J, Savic RM, Gengenbacher M, Podell BK, Prideaux B, Ioerger T, Dick T, Dartois V

Open source

DOI: 10.1084/jem.20180518
Published: 2018 Aug 6
Container: The Journal of experimental medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1084/jem.20180518,
  title = {Impact of immunopathology on the antituberculous activity of pyrazinamide.},
  author = {Blanc L and Sarathy JP and Alvarez Cabrera N and O'Brien P and Dias-Freedman I and Mina M and Sacchettini J and Savic RM and Gengenbacher M and Podell BK and Prideaux B and Ioerger T and Dick T and Dartois V},
  year = {2018},
  journal = {The Journal of experimental medicine},
  doi = {10.1084/jem.20180518},
  url = {https://doi.org/10.1084/jem.20180518}
}

RIS

TY  - JOUR
TI  - Impact of immunopathology on the antituberculous activity of pyrazinamide.
AU  - Blanc L
AU  - Sarathy JP
AU  - Alvarez Cabrera N
AU  - O'Brien P
AU  - Dias-Freedman I
AU  - Mina M
AU  - Sacchettini J
AU  - Savic RM
AU  - Gengenbacher M
AU  - Podell BK
AU  - Prideaux B
AU  - Ioerger T
AU  - Dick T
AU  - Dartois V
PY  - 2018
JO  - The Journal of experimental medicine
DO  - 10.1084/jem.20180518
UR  - https://doi.org/10.1084/jem.20180518
ER  -

APA

L, B., JP, S., N, A. C., P, O., I, D., M, M., J, S., RM, S., M, G., BK, P., B, P., T, I., T, D., & V, D. (2018). Impact of immunopathology on the antituberculous activity of pyrazinamide.. The Journal of experimental medicine. https://doi.org/10.1084/jem.20180518

Source records

pubmed · retrieved 2026-09-26T11:17:47.404Z